BACKGROUND: Although there is abundant information about bacterial periprosthetic joint infections (PJIs), there is a notable paucity of information about fungal PJIs. The goals of this study are to describe the patient demographics, diagnostic findings, and treatment results of fungal PJIs after total joint arthroplasty. METHODS: We identified 31 fungal PJIs (13 total hip arthroplasties and 18 total knee arthroplasties) in 31 patients treated between 1996 and 2014. This represented 0.9% of the 3525 PJIs treated at our institution during this time period. Candida species accounted for 81% of infections. The mean patient age at diagnosis of fungal PJI was 68 years. Mean follow-up after initiation of treatment was 4 years. RESULTS: In the total hip arthroplasty cohort, survivorship free from all-cause revision or implant removal was 44% at 2 years. Survivorship free from reinfection was 38% at 2 years. Mean Harris hip score was 27 at final follow-up.In the total knee arthroplasty cohort, survivorship free from all-cause revision was 70% at 2 years. Survivorship free from reinfection was 76% at 2 years. Mean Knee Society scores were 36 at final follow-up. CONCLUSION: Fungal PJIs are rare (0.9% of diagnosed PJIs). Survivorship free of all-cause revision or implant removal was very low in the hip group (44% at 2 years), but slightly better in the knee group (70% at 2 years). Moreover, clinical outcomes were poor with high perioperative complication rates. Improved treatment regimens are needed for this unsolved clinical problem.
BACKGROUND: Although there is abundant information about bacterial periprosthetic joint infections (PJIs), there is a notable paucity of information about fungal PJIs. The goals of this study are to describe the patient demographics, diagnostic findings, and treatment results of fungal PJIs after total joint arthroplasty. METHODS: We identified 31 fungal PJIs (13 total hip arthroplasties and 18 total knee arthroplasties) in 31 patients treated between 1996 and 2014. This represented 0.9% of the 3525 PJIs treated at our institution during this time period. Candida species accounted for 81% of infections. The mean patient age at diagnosis of fungal PJI was 68 years. Mean follow-up after initiation of treatment was 4 years. RESULTS: In the total hip arthroplasty cohort, survivorship free from all-cause revision or implant removal was 44% at 2 years. Survivorship free from reinfection was 38% at 2 years. Mean Harris hip score was 27 at final follow-up.In the total knee arthroplasty cohort, survivorship free from all-cause revision was 70% at 2 years. Survivorship free from reinfection was 76% at 2 years. Mean Knee Society scores were 36 at final follow-up. CONCLUSION: Fungal PJIs are rare (0.9% of diagnosed PJIs). Survivorship free of all-cause revision or implant removal was very low in the hip group (44% at 2 years), but slightly better in the knee group (70% at 2 years). Moreover, clinical outcomes were poor with high perioperative complication rates. Improved treatment regimens are needed for this unsolved clinical problem.
Authors: Fortune J Egbulefu; JaeWon Yang; John C Segreti; Scott M Sporer; Antonia F Chen; Matthew S Austin; Craig J Della Valle Journal: Arthroplast Today Date: 2022-08-27
Authors: Abigail A Weaver; Nur A Hasan; Mark Klaassen; Hiren Karathia; Rita R Colwell; Joshua D Shrout Journal: J Med Microbiol Date: 2019-10 Impact factor: 3.196
Authors: Talha Riaz; Aaron J Tande; Lisa L Steed; Harry A Demos; Cassandra D Salgado; Douglas R Osmon; Camelia E Marculescu Journal: J Bone Jt Infect Date: 2020-03-26
Authors: Hadi E Berbari; Pooja Gurram; Maryam Mahmood; Paul J Deziel; Randall C Walker; Raymund R Razonable Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2021-01-21
Authors: Sven Frieler; Emre Yilmaz; Ryan Goodmanson; Yannik Hanusrichter; Thomas A Schildhauer; Hinnerk Baecker Journal: Arthroplast Today Date: 2020-12-05
Authors: Andreas Enz; Silke C Mueller; Philipp Warnke; Martin Ellenrieder; Wolfram Mittelmeier; Annett Klinder Journal: J Fungi (Basel) Date: 2021-05-21
Authors: Daniel Pérez-Prieto; Pedro Hinarejos; Albert Alier; Lluïsa Sorlí; Santos Martínez; Lluís Puig; Juan C Monllau Journal: BMC Musculoskelet Disord Date: 2021-08-02 Impact factor: 2.362
Authors: Sebastian Oenning; Burkhard Moellenbeck; Georg Gosheger; Tom Schmidt-Bräkling; Jan Schwarze; Thomas Ackmann; Kristian Nikolaus Schneider; Christoph Theil Journal: Arthroplast Today Date: 2020-08-27